Nu Skin Enterprises, INC 10-Q quarterly reports

Nu Skin Enterprises experienced a substantial net loss of $249.8 million in Q2 2026, driven by a 17.1% revenue decrease and a significant goodwill impairment charge.

Nu Skin Enterprises reports increased Q3 2025 earnings per share driven by cost management and a business sale, despite a significant decline in overall revenue and customer metrics.

Nu Skin Enterprises reported a significant increase in net income and EPS for Q2 2025, primarily driven by the sale of its Mavely business, despite a 12% decline in overall revenue and a drop in customer and sales force metrics.

Nu Skin Enterprises' Q1 2025 results show a net income increase driven by the sale of Mavely, despite a revenue decrease.

Nu Skin Enterprises experienced a 14% revenue decrease in the third quarter of 2024, alongside restructuring and impairment charges, but saw a positive shift in earnings per share compared to the previous year.

Nu Skin Enterprises reported a substantial net loss for the second quarter of 2024, primarily due to restructuring and impairment charges, alongside a decline in revenue.

Nu Skin Enterprises experienced a revenue decline in the first quarter of 2024, impacted by macroeconomic challenges and restructuring, though partially offset by growth in its Rhyz segment.